Caption Management, LLC

Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.

CIK 1706766 OKLAHOMA CITY, OK

Back to CRBP Full portfolio

Position in CRBP

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$60,753

-$395,624 QoQ

Shares Held

6,470

-88.5% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

5 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CRBP Over Time

Shares Held

Position Value (USD)

Derivatives in CRBP

reported options exposure · as of Sep 30, 2025

CallValue

CallShares

PutValue

$1,012,000

PutShares

80,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Caption Management, LLC holds $195,300,170 across 69 Biotechnology names. CRBP ranks #60 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CGON	CG Oncology, Inc.	378,480	$25,615,526
2	IMCR	Immunocore Holdings plc	661,786	$19,952,847
3	CYTK	Cytokinetics Inc	245,000	$16,147,950
4	ELVN	Enliven Therapeutics, Inc.	370,000	$14,504,000
5	SLNO	Soleno Therapeutics Inc	420,143	$14,066,387
6	CNTA	Centessa Pharmaceuticals plc	274,116	$10,887,887
7	CORT	Corcept Therapeutics Inc	260,000	$10,480,600
8	HRMY	Harmony Biosciences Holdings, Inc.	272,292	$7,626,898

All Filings in CRBP

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$60,753	6,470	-88.5%	Shares	Sole	2026-05-15
2025-12-31	$456,377	56,066	-29.9%	Shares	Sole	2026-02-17
2025-09-30	$1,012,000	80,000	+98.0%	Put	Sole	2025-11-14
2024-09-30	$833,452	40,400	+92.4%	Put	Sole	2024-11-14
2024-03-31	$824,040	21,000	0.0%	Put	Sole	2024-05-15
2024-03-31	$824,040	21,000	—	Call	Sole	2024-05-15
No filing history on record for this holder in this stock.